Why the study?
Can the steady-state beta-blocking effect of oral bisoprolol be predicted by the plasma concentration-effect relationship after an acute i.v. dose in healthy volunteers?
Can the steady-state beta-blocking effect of oral bisoprolol be predicted by the plasma concentration-effect relationship after an acute i.v. dose in healthy volunteers?
The intensity of bisoprolol-induced beta-blockade after repeated oral dosing can be accurately predicted by a single-test i.v. dose administration.
Answers are grounded in this paper and cite their sources.
Acute IV PK/PD modeling predicts steady-state oral beta-blockade; extends individualized dosing strategies for clinicians and validates PK/PD approaches for researchers.
Bisoprolol is a selective beta 1-adrenoceptor antagonist devoid of partial agonist activity that can be used for treatment of chronic and acute myocardial ischemia. In this condition, it is important to demonstrate that a stable beta-blocking effect at steady state can be predicted by a mathematical model determined by plasma concentration-effect relationship after an acute intravenous (i.v.) dose. This relation was studied in 10 healthy volunteers in a double-blind, randomized, cross-over, placebo-controlled study after a 5-min i.v. infusion of bisoprolol (5 mg) or placebo. Standardized exercise tests were recorded at different times for 48 h after infusion with simultaneous bisoprolol assay (high-performance liquid chromatography, HPLC) in plasma. After a 1-week interval, subjects received oral bisoprolol (10 mg once daily) for 5 days and exercise tests were repeated on day 5 before and 2, 3, and 4 h after dosing, with bisoprolol plasma level determined simultaneously. In the acute period, bisoprolol significantly decreased exercise heart rate (HR: peak effect -20.5 +/- 4%) as compared with placebo. There was a direct relationship (no hysteresis) between beta-blockade and plasma concentrations with a sigmoid (7 subjects) or a linear (3 subjects) best-fit model. After repeated bisoprolol administration, steady-state plasma levels were achieved and 88% of the observed decreases in exercise HR were within the 95% confidence interval (CI) for individual prediction. These data suggest that bisoprolol-induced beta-blockade after repeated oral dosing can be predicted by single-test i.v. dose administration.
No takes yet. Share an insight, caveat, or question.
Jamin et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: